drugset / Trial / NCT01998620
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an evaluation of adenosine methionine for treatment of chronic hepatitis b patients with cholestasis efficacy and safety of multicenter, randomized, open label clinical trial.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ademetionine | Unknown | 500 mg | Intravenous |
| Subject | Ademetionine | Unknown | 1000 mg | Intravenous |